Joel Besse is an active angel investor and strategic advisor with a focused thesis on life sciences, deeptech, and foodtech, investing from pre-seed to Series A. His extensive background includes founding Momentum Biotech, nearly two decades of healthcare consulting through Affas Besse Advisors, and a key advisory role at Save the Children Global Ventures, providing him with a unique blend of investment acumen and deep operational insight.

His portfolio reflects a preference for scientifically complex and impactful ventures, including Owkin (AI-biotech), Astrocyte Pharmaceuticals (neuroprotection), and Core Biogenesis (sustainable bioproduction). Joel offers founders more than capital; he provides strategic guidance, sector-specific networks, and support for companies targeting global scale and significant health or societal impact.